Developments Enlivex posts positive COVID-19 results in severe/critical patients Enlivex Therapeutics (NASDAQ:ENLV) reported positive topline results of an investigator-initiated clinical trial of Allocetra in five COVID-19 patients, three of which were in severe condition and two in critical... October 1, 2020